4 FDA actions
VANFLYTA (QUIZARTINIB)
DAIICHI SANKYO INC
TURALIO (PEXIDARTINIB HYDROCHLORIDE)
DATROWAY
SAVAYSA (EDOXABAN TOSYLATE)